Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Methylprednisolone acetate
Drug ID BADD_D01434
Description Not Available
Indications and Usage Not Available
Marketing Status Not Available
ATC Code Not Available
DrugBank ID Not Available
KEGG ID D00979
MeSH ID D000077555
PubChem ID 5877
TTD Drug ID Not Available
NDC Product Code 0009-0026; 10695-041; 38779-0144; 46439-8767; 82298-117; 0009-0274; 50090-6024; 60219-1574; 0009-0306; 68788-8082; 76420-262; 0781-3516; 51552-0958; 0009-3073; 76420-260; 25021-821; 0009-0280; 50090-0436; 49452-4688; 71052-161; 25021-820; 70121-1552; 76420-081; 60722-1007; 0009-3475; 55150-313; 63187-474; 70121-1573; 70121-1574; 52128-148; 42023-239; 42023-240; 55150-314; 51927-0000; 63275-9942; 65089-0016; 50090-0556; 51662-1429; 22552-0023; 50090-5894; 60219-1573
UNII 43502P7F0P
Synonyms Methylprednisolone Acetate | Methylprednisolone-21-acetate | Methylprednisolone 21 acetate | Acetyl-Methylprednisolone | Acetyl Methylprednisolone | Depo-Medrone | Depo Medrone | Depo-Medrol | Depo Medrol | Methylprednisolone Acetate, (11beta,16beta)-isomer | Methylprednisolone Acetate, (11beta,16alpha)-isomer
Chemical Information
Molecular Formula C24H32O6
CAS Registry Number 53-36-1
SMILES CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)COC(=O)C)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Haemorrhage24.07.01.002--Not Available
Muscle mass15.05.03.018--Not Available
Cognitive disorder19.21.02.001; 17.03.03.003--
Dyslipidaemia14.08.04.015--Not Available
Angiopathy24.03.02.007--Not Available
Blood alkaline phosphatase increased13.04.02.004--
Hepatic enzyme increased13.03.04.028--Not Available
Skin test negative13.06.04.002--Not Available
Breast disorder21.05.04.004--Not Available
Cardiac disorder02.11.01.003--Not Available
Connective tissue disorder10.04.04.026; 15.06.01.006--Not Available
Embolism24.01.01.009--
Infestation23.11.01.002; 11.09.01.001--Not Available
Lipid metabolism disorder14.08.04.003--Not Available
Lipomatosis14.08.04.011--Not Available
Malnutrition14.03.02.004--Not Available
Mediastinal disorder22.09.03.001--Not Available
Mental disorder19.07.01.002--Not Available
Abnormal behaviour19.01.01.001--Not Available
Ill-defined disorder08.01.03.049--Not Available
Inner ear disorder04.04.02.002--Not Available
Psychotic disorder19.03.01.002--
Chorioretinopathy06.09.01.006--Not Available
Latent tuberculosis11.04.01.009--Not Available
Administration site infection12.07.04.008; 11.01.08.044; 08.02.04.008--Not Available
Epidural lipomatosis14.08.04.019; 17.10.01.012--Not Available
Injection site exfoliation23.03.07.008; 12.07.03.030; 08.02.03.030--Not Available
Bladder dysfunction20.03.03.002--Not Available
Sperm concentration abnormal13.20.04.007--Not Available
Functional gastrointestinal disorder07.11.01.016--Not Available
The 7th Page    First    Pre   7 8    Next   Last    Total 8 Pages